PreludeDx Presents New Data Demonstrating Utility of DCISionRT to De-escalate Radiation Therapy for Women with DCIS itnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnonline.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Prelude Corporation (PreludeDx™), a leader in precision diagnostics for early-stage breast cancer, presented data on the use of DCISionRT® to.
/PRNewswire/ Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced it.
Women who undergo double mastectomy have the least amount of decision regret. Guideline groups need to take heed, say new survey authors. But was the study representative?